Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
XRF ScientificASX:XRF -1.47%98 EV-to-EBIT is 15.02 as of Jul. 18, 2026, which is 17% above its 10-year median of 12.82. GuruFocus rates ASX:XRF with a GF Score™ of 98/100 and a GF Value™ of A$1.66 (Fairly Valued). The stock has 1 warning sign investors should review. Among 458 Conglomerates companies, XRF Scientific ranks worse than 62.88% on this metric.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
XRF Scientific's Enterprise Value for the quarter that ended in Dec. 2025 was A$284.90 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. XRF Scientific's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was A$15.35 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XRF Scientific EV-to-EBIT Related Terms
XRF Scientific EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for XRF Scientific's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Conglomerates subindustry, XRF Scientific's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
XRF Scientific EV-to-EBIT vs Conglomerates Industry
For the Conglomerates industry and Industrials sector, XRF Scientific's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where XRF Scientific's EV-to-EBIT falls into.
XRF Scientific's current Enterprise Value is A$230.65 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. XRF Scientific's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was A$15.35 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XRF Scientific (ASX:XRF) has a EV-to-EBIT of 15.02 as of Jul. 18, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on XRF Scientific and its competitors. This is 17% above median its historical median of 12.82. Over the past decade, XRF Scientific's EV-to-EBIT has ranged from 5.66 to 28.76. According to the industry distribution chart, XRF Scientific ranks #288 out of 458 companies in the Conglomerates industry, placing it in the top 62.9%.
Is XRF Scientific's EV-to-EBIT too high?
XRF Scientific's current EV-to-EBIT of 15.02 is 17% above median its 10-year median of 12.82. Over the past 10 years, this metric has ranged from a low of 5.66 to a high of 28.76. The Conglomerates industry median EV-to-EBIT is 11.68. XRF Scientific's value of 15.02 is 28.6% above this industry median. Based on the distribution chart, XRF Scientific ranks #288 out of 458 companies in the Conglomerates industry, which is below the industry midpoint. Overall, XRF Scientific has a GF Score™ of 98/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does XRF Scientific's EV-to-EBIT compare to HON and MMM?
According to the Conglomerates industry distribution chart, XRF Scientific ranks #288 out of 458 companies for EV-to-EBIT. This places XRF Scientific in the lower half of its industry. The industry median EV-to-EBIT is 11.68. XRF Scientific's value of 15.02 is 28.6% above this benchmark. Historically, XRF Scientific's own EV-to-EBIT has ranged from 5.66 to 28.76 over the past decade. While the company's 10-year median is 12.82 vs. the industry median of 11.68, XRF Scientific has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Conglomerates company?
The median EV-to-EBIT among Conglomerates companies is 11.68, based on 458 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. XRF Scientific's current EV-to-EBIT of 15.02 is 28.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on XRF Scientific and its competitors. For the Conglomerates industry, the median EV-to-EBIT is 11.68 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. XRF Scientific's current EV-to-EBIT is 15.02, which is 17% above median its own 10-year median of 12.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is XRF Scientific stock overvalued right now?
Based on GuruFocus' analysis, XRF Scientific (ASX:XRF) is currently considered Fairly Valued. The stock's GF Value™ is A$1.66, compared to a current price of A$1.68 — trading 1.2% above its estimated fair value. The current EV-to-EBIT is 15.02, which is 17% above median its 10-year median of 12.82 and 28.6% above the Conglomerates industry median of 11.68. XRF Scientific's overall GF Score™ is 98/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For XRF Scientific (ASX:XRF), the current EV-to-EBIT is 15.02 as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is XRF Scientific (ASX:XRF) Overvalued in 2026?
Based on GuruFocus' analysis, XRF Scientific stock appears to be overvalued.
The current stock price of A$1.68 is trading 1.2% above its estimated GF Value™ of A$1.66.
GuruFocus considers XRF Scientific to be Fairly Valued.
Key valuation signals for ASX:XRF:
EV-to-EBIT: 15.02 (17% above median its 10-year median of 12.82)
GF Value™: A$1.66 vs. price of A$1.68 (1.2% above fair value)
Industry Position: 28.6% above the Conglomerates median (#288 of 458)
No single metric tells the full story. See the ASX:XRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
XRF Scientific Ltd is engaged in the business of manufacturing and marketing precious metal products, specialized chemicals and instruments for the scientific, analytical and mining industries. It operates through the following segments: Capital Equipment, Precious Metals, and Consumables. The company generates maximum revenue from the Capital Equipment segment that Manufactures sample preparation products and analytical instruments. Geographically, it derives a majority of revenue from Australia and also has a presence in Canada and Europe. Some of its product includes Electric Fusion Machines; Fusion Flux; Crushing and Pulverising, platinum lab ware and others.
98GF Score
Get the complete analysis for ASX:XRF
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:XRF has been successfully added to your 
